is a digital drug development organization with a vision to revolutionize the pharmaceutical industry by integrating innovative technologies into the drug development process. Founded in 2009 and based in the United States, iDD aims to provide end-to-end solutions for drug development, leveraging cutting-edge digital tools and platforms, including e-Source, e-ICF, e-TMF, Digital Protocol, and Digital/Virtual Clinical Trial. The company's flagship product, the i-Trial Concept, offers a virtual trial management process that enables real-time access to data and proactive risk identification. iDD's technology-driven approach not only streamlines the clinical study conduct remotely but also significantly reduces the cost and time of drug development. Additionally, its trigger system utilizes predictive analytics to address risks faster than ever before. In addition to its technological solutions, iDD offers high-quality, cost-effective clinical trial management services to a wide range of industries, including pharmaceutical, biotechnology, neutraceuticals, cosmetic, and medical device companies. The company's dedication to providing flexible and tailored solutions makes it a valuable partner for organizations seeking efficient and innovative approaches to drug development challenges.
There is no investment information
No recent news or press coverage available for IDD Research Solutions INC (former I5 Clinical Research Pvt.Ltd).